French teachers in the city of Nice have overwhelmingly rejected AstraZeneca’s COVID jab after just 58 out of a possible 3,000 signed up to be vaccinated.
The jabs were being offered at a mass vaccination centre in Nice’s Palais des Expositions this weekend, with 4,000 available to those aged over 55 in high-risk occupations, meaning 3,000 teachers eligible to take part.
But the centre was forced to close after just four hours on Saturday due to lack of demand with just 58 appointments registered, and did not reopen today despite being scheduled to do so.
That means the take-up rate among eligible teachers was just 2 per cent, with one local official blaming vaccine hesitancy caused by scaremongering around the British-made jab.
Anne Frackowiak-Jacobs, sub-prefect of nearby Grasse, said people had ‘turned around’ when they learned they would be given AstraZeneca.
Macron previously described the AstraZeneca jab as ‘quasi-ineffective’ in older people and limited its use to the young, before flip-flopping after data suggested a link to very rare blood clots in the young, restricting it to older people instead.
That has led to ‘vaccine hesitancy’ among French people – already Europe’s biggest vaccine-skeptics – with a survey last month showing 61 per cent of people now think the AstraZeneca jab is ‘unsafe.’
Local officials tried to claim that vaccines had been advertised late and restrictions on age and occupation were also to blame for appointments going un-used.
But Ms Frackowiak-Jacobs said it actually shows that French people have ‘no confidence’ in the British-made jab, despite world health authorities and Europe’s own regulator saying the benefits far outweigh the risks.
The vaccination centre in Nice is now due to reopen on Monday and will instead offer Pfizer and Moderna jabs in the hopes of attracting more interest.
The AstraZeneca jabs will instead be sent to a nearby fire station to be used by government employees on the priority list, Nice Martin reported.
The scenes of empty vaccination centres played out in Nice even as France reports rising Covid cases with infections almost back to their second wave peak, despite a nationwide lockdown.
On Saturday, the country reported another 35,000 new ‘cases’, bringing the overall total to 5.2million, and another 189 deaths.
France’s COVID death toll now stands at more than 100,000, a grim benchmark that it passed on Thursday.
France is currently in lockdown, and Mr Macron has been severely criticised for the slowness of vaccine roll-out, compared to neighbours including the UK.
Some 12million people have so far received at least a first dose of vaccine against Coronavirus in France, or 18.4 per cent of the population.
This compares to around 4.5million people, or 6.6 per cent of France’s population, who have received a second dose.
Despite this, thousands of doses of the Anglo-Swedish developed Oxford AstraZeneca are being wasted following panic created by President Macron.
Political opponents suggested the notoriously anti-Brexit president had partly questioned its safety and effectiveness so as to attack the UK.
Natacha Bouchart, the Mayor of Calais, is among those who have referred to a ‘wave of panic’ created by Mr Macron, saying: ‘There really has to be a national campaign to explain that this vaccine has no more negative consequences than the ones from Pfizer or Moderna.’
Mr Macron announced that the use of AstraZeneca was being suspended last month ‘as a precaution’.
He at first said it was dangerous for people aged over 65, and then reviewed this to say that those under 55 should avoid it.
This was around the time that Mr Macron’s own prime minister, Jean Castex, was having an AstraZeneca jab.
Source: MailOnline – Daily Mail
Header: Nurses clean and adjust an endotracheal tube providing respiratory assistance to a 61-year-old COVID-19 patient at the ICU in the La Timone hospital in Marseille, southern France, Thursday, Nov. 12, 2020. In Marseille the second wave of the coronavirus is bringing even more people to the ICU than the first one in the spring, many in more severe condition. (AP Photo/Daniel Cole)